- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY 3.00 Å
- Oligo State
- homo-trimer
- Ligands
- 10 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 6 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA.2: 5 residues within 4Å:- Chain A: Y.160, N.174
- Chain C: G.533, V.536, Q.537
2 PLIP interactions:2 interactions with chain C- Hydrogen bonds: C:V.536, C:Q.537
NAG-NAG-BMA.4: 6 residues within 4Å:- Chain A: G.128, N.132, E.257, H.258, A.259, Y.282
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.8: 7 residues within 4Å:- Chain B: G.128, A.131, N.132, E.257, H.258, A.259, Y.282
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.9: 6 residues within 4Å:- Chain A: L.532, G.533, V.536, Q.537
- Chain B: Y.160, N.174
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.13: 5 residues within 4Å:- Chain C: G.128, N.132, E.257, H.258, Y.282
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.14: 4 residues within 4Å:- Chain B: G.533, V.536, Q.537
- Chain C: N.174
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:Q.537
- 3 x EIC: LINOLEIC ACID(Non-covalent)
EIC.17: 18 residues within 4Å:- Chain A: F.393, M.396, Y.417, L.419, F.426, V.428, F.431, P.438, L.441, I.488, A.490, F.570, I.572
- Chain C: S.462, Y.463, S.468, T.469, G.470
16 PLIP interactions:14 interactions with chain A, 2 interactions with chain C- Hydrophobic interactions: A:F.393, A:L.419, A:F.426, A:F.426, A:V.428, A:F.431, A:P.438, A:L.441, A:I.488, A:I.488, A:A.490, A:F.570, A:F.570, A:I.572, C:T.469
- Hydrogen bonds: C:G.470
EIC.31: 16 residues within 4Å:- Chain A: S.462, Y.463, S.468, G.470
- Chain B: F.393, Y.417, L.419, L.423, F.426, V.428, F.431, P.438, L.441, I.488, F.570, I.572
13 PLIP interactions:13 interactions with chain B- Hydrophobic interactions: B:F.393, B:L.419, B:F.426, B:F.426, B:V.428, B:F.431, B:P.438, B:L.441, B:I.488, B:I.488, B:F.570, B:F.570, B:I.572
EIC.44: 16 residues within 4Å:- Chain B: Y.463, S.468, T.469
- Chain C: F.393, Y.417, L.419, L.422, L.423, F.426, V.428, F.431, P.438, L.441, I.488, F.570, I.572
15 PLIP interactions:14 interactions with chain C, 1 interactions with chain B- Hydrophobic interactions: C:F.393, C:L.419, C:L.422, C:F.426, C:F.426, C:V.428, C:F.431, C:P.438, C:L.441, C:I.488, C:I.488, C:F.570, C:F.570, C:I.572, B:T.469
- 38 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.18: 2 residues within 4Å:- Chain A: N.66, V.337
Ligand excluded by PLIPNAG.19: 5 residues within 4Å:- Chain A: P.37, Q.41, N.111, N.114, E.115
Ligand excluded by PLIPNAG.20: 2 residues within 4Å:- Chain A: G.162, N.163
Ligand excluded by PLIPNAG.21: 3 residues within 4Å:- Chain A: T.165, N.166, N.167
Ligand excluded by PLIPNAG.22: 3 residues within 4Å:- Chain A: D.24, P.197, N.241
Ligand excluded by PLIPNAG.23: 1 residues within 4Å:- Chain A: N.252
Ligand excluded by PLIPNAG.24: 3 residues within 4Å:- Chain A: N.591
- Chain C: A.515, F.516
Ligand excluded by PLIPNAG.25: 2 residues within 4Å:- Chain A: N.618, N.646
Ligand excluded by PLIPNAG.26: 4 residues within 4Å:- Chain A: Q.706, N.717, S.719, L.751
Ligand excluded by PLIPNAG.27: 3 residues within 4Å:- Chain A: N.755, R.758
- Chain B: Y.878
Ligand excluded by PLIPNAG.28: 2 residues within 4Å:- Chain A: N.777, Y.1185
Ligand excluded by PLIPNAG.29: 2 residues within 4Å:- Chain A: N.862, T.864
Ligand excluded by PLIPNAG.30: 5 residues within 4Å:- Chain A: S.768, Q.1201, T.1203, F.1205, N.1207
Ligand excluded by PLIPNAG.32: 2 residues within 4Å:- Chain B: N.66, V.337
Ligand excluded by PLIPNAG.33: 4 residues within 4Å:- Chain B: I.161, G.162, N.163, N.167
Ligand excluded by PLIPNAG.34: 2 residues within 4Å:- Chain B: T.165, N.167
Ligand excluded by PLIPNAG.35: 4 residues within 4Å:- Chain B: D.24, I.196, P.197, N.241
Ligand excluded by PLIPNAG.36: 1 residues within 4Å:- Chain B: N.252
Ligand excluded by PLIPNAG.37: 2 residues within 4Å:- Chain A: F.516
- Chain B: N.591
Ligand excluded by PLIPNAG.38: 2 residues within 4Å:- Chain B: N.618, N.646
Ligand excluded by PLIPNAG.39: 3 residues within 4Å:- Chain B: Q.706, N.717, L.751
Ligand excluded by PLIPNAG.40: 4 residues within 4Å:- Chain B: V.753, N.755, R.758
- Chain C: Y.878
Ligand excluded by PLIPNAG.41: 2 residues within 4Å:- Chain B: N.777, Y.1185
Ligand excluded by PLIPNAG.42: 3 residues within 4Å:- Chain B: N.862, T.864, N.998
Ligand excluded by PLIPNAG.43: 4 residues within 4Å:- Chain B: S.768, T.1203, F.1205, N.1207
Ligand excluded by PLIPNAG.45: 2 residues within 4Å:- Chain C: N.66, V.337
Ligand excluded by PLIPNAG.46: 5 residues within 4Å:- Chain C: P.37, Q.41, N.111, N.114, E.115
Ligand excluded by PLIPNAG.47: 4 residues within 4Å:- Chain C: G.162, N.163, N.167
- Ligands: NAG.48
Ligand excluded by PLIPNAG.48: 3 residues within 4Å:- Chain C: T.165, N.167
- Ligands: NAG.47
Ligand excluded by PLIPNAG.49: 5 residues within 4Å:- Chain C: D.24, I.196, P.197, R.198, N.241
Ligand excluded by PLIPNAG.50: 1 residues within 4Å:- Chain C: N.252
Ligand excluded by PLIPNAG.51: 1 residues within 4Å:- Chain C: N.591
Ligand excluded by PLIPNAG.52: 2 residues within 4Å:- Chain C: N.618, N.646
Ligand excluded by PLIPNAG.53: 4 residues within 4Å:- Chain C: Q.706, N.717, S.719, L.751
Ligand excluded by PLIPNAG.54: 4 residues within 4Å:- Chain A: Y.878
- Chain C: V.753, N.755, R.758
Ligand excluded by PLIPNAG.55: 1 residues within 4Å:- Chain C: N.777
Ligand excluded by PLIPNAG.56: 2 residues within 4Å:- Chain C: N.862, T.864
Ligand excluded by PLIPNAG.57: 5 residues within 4Å:- Chain C: S.768, T.1203, F.1205, E.1206, N.1207
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Yuan, H. et al., Structures and receptor binding activities of merbecovirus spike proteins reveal key signatures for human DPP4 adaptation. Sci Adv (2025)
- Release Date
- 2025-06-18
- Peptides
- Spike glycoprotein,Fibritin: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
C
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY 3.00 Å
- Oligo State
- homo-trimer
- Ligands
- 10 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 6 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 3 x EIC: LINOLEIC ACID(Non-covalent)
- 38 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Yuan, H. et al., Structures and receptor binding activities of merbecovirus spike proteins reveal key signatures for human DPP4 adaptation. Sci Adv (2025)
- Release Date
- 2025-06-18
- Peptides
- Spike glycoprotein,Fibritin: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
C